Skip to main content
. 2021 Nov 11;53(1):2072–2089. doi: 10.1080/07853890.2020.1841281

Figure 5.

Figure 5.

Summary of the effects of the SGLT2 inhibitors on the major kidney outcomes (A) and (B) from EMPA-REG, CANVAS and DECLARE, (C) also incorporating CREDENCE data [39,68].